Article
Rheumatology
Laura C. Coates, Nadia Corp, Danielle A. van der Windt, Denis O'Sullivan, Enrique R. Soriano, Arthur Kavanaugh
Summary: The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (G RAPPA) has been committed to developing treatment recommendations for patients with psoriatic arthritis (PsA) since its inception. In 2020-2021, they updated the recommendations based on new data and presented proposals at the annual meeting, including input from patients and clinicians. The draft of the treatment recommendations was discussed with the wider membership.
JOURNAL OF RHEUMATOLOGY
(2022)
Article
Rheumatology
Philip J. Measel, Kevin Winthrop, Wendy Olsder, Jeffrey R. Curtis
Summary: The efficacy and safety of COVID-19 vaccination in patients with autoimmune inflammatory diseases who are treated with immunomodulatory therapies were discussed at a virtual symposium. The keynote speaker provided guidance on vaccine response modification and emphasized the importance of vaccination for increased protection against COVID-19. Patient research partners expressed concerns about vaccine efficacy and safety, ongoing social habits, and medication management during the panel discussion.
JOURNAL OF RHEUMATOLOGY
(2022)
Article
Rheumatology
Jenna E. Yousif, Joseph F. Merola, Lourdes M. Perez-Chada, Caterina Zagona-Prizio, April W. Armstrong, Alexis Ogdie, Sangyoon Shin, Alice B. Gottlieb
Summary: The IDEOM initiative provided an update on the development of patient-centered outcome measures for psoriasis and psoriatic arthritis at the GRAPPA annual meeting. The Treatment Satisfaction working group introduced a specific questionnaire for dermatological conditions, while the Musculoskeletal Symptoms working group discussed the implementation of a screening tool for identifying PsA in psoriasis patients or preventing symptom worsening.
JOURNAL OF RHEUMATOLOGY
(2022)
Article
Rheumatology
Leonieke J. J. van Mens, Gizem Ayan, Laura C. Coates, Roxana Coras, Dimitri L. F. Silva, Sebastian Herrera, Alla Ishchenko, Hannah Jethwa, Hanna Johnsson, David Simon, Arani Vivekanantham, Fabian Proft
Summary: At the 2021 GRAPPA annual meeting, a separate group called Young-GRAPPA was established to address the challenges faced by young researchers and physicians at the beginning of their careers. This paper presents the initial organizational framework, different components, and aims of this group. Over 50 young researchers were successfully enrolled as a result of this meeting.
JOURNAL OF RHEUMATOLOGY
(2022)
Article
Respiratory System
Fuad Mirzayev, Kerri Viney, Nguyen Nhat Linh, Lice Gonzalez-Angulo, Medea Gegia, Ernesto Jaramillo, Matteo Zignol, Tereza Kasaeva
Summary: Antimicrobial resistance is a significant global public health issue, as is the challenge posed by drug-resistant forms of tuberculosis. The World Health Organization has recently updated their guidelines for the treatment of MDR and RR TB, recommending shorter, all-oral regimens and emphasizing the importance of individualized treatment plans.
EUROPEAN RESPIRATORY JOURNAL
(2021)
Review
Rheumatology
Cristiano B. Campanholo, Ajesh B. Maharaj, Nadia Corp, Stacie Bell, Luisa Costa, Kurt de Vlam, Nicola J. Gullick, Majed Khraishi, Mitsumasa Kishimoto, Natalia Palmou-Fontana, Soumya Reddy, Raffaele Scarpa, Luis Vega, Gleison Vieira Duarte, Devy Zisman, Danielle A. van der Windt, Mehmet T. Duruoz, Alexis Ogdie
Summary: The 2021 GRAPPA treatment recommendations provide evidence-based guidance for selecting therapy based on individual disease features. Comorbidities also play a significant role in therapy selection for psoriatic arthritis (PsA), and need to be assessed prior to treatment selection.
JOURNAL OF RHEUMATOLOGY
(2023)
Review
Dermatology
Alison H. Kohn, Afsaneh Alavi, April W. Armstrong, Folawiyo Babalola, Amit Garg, Alice B. Gottlieb, Lesley Grilli, Gregor Borut Ernst Jemec, John Latella, Kendall Marcus, Joseph F. Merola, Alex G. Ortega-Loayza, Daniel M. Siegel, Vibeke Strand, Jerry K. L. Tan, Lourdes M. Perez-Chada
Summary: This report summarizes the work presented by each IDEOM workgroup (psoriasis, psoriatic arthritis, hidradenitis suppurativa, acne, pyoderma gangrenosum, and actinic keratosis) at the 2020 IDEOM Virtual Annual Meeting.
Article
Rheumatology
Kristina Callis Duffin, Dafna D. Gladman, Niti Goel, Alice B. Gottlieb, Oliver FitzGerald, Lynne V. McFarland
Summary: The virtual annual meeting of GRAPPA in 2021 focused on education, research, and clinical care of psoriatic disease, providing a variety of sessions and updates.
JOURNAL OF RHEUMATOLOGY
(2022)
Review
Oncology
Jing-Zhou Hou, Jing Christine Ye, Jeffrey J. Pu, Hongtao Liu, Wei Ding, Hong Zheng, Delong Liu
Summary: Antibodies and CAR-T cells are increasingly used in cancer immunotherapy for hematological malignancies. Small molecule inhibitors targeting oncoproteins and enzymes have been approved for several major hematological malignancies. Updates on novel agents and regimens from clinical trials were presented at the recent ASH annual meeting and other conferences.
JOURNAL OF HEMATOLOGY & ONCOLOGY
(2021)
Review
Rheumatology
Ennio Lubrano, Jon Chan, Ruben Queiro-Silva, Alberto Cauli, Niti Goel, Denis Poddubnyy, Peter Nash, Dafna D. Gladman
Summary: Objective. The objective of this study was to identify and evaluate the efficacy of therapeutic interventions for treatment of axial disease in PsA. Methods. This systematic review updated the treatment recommendations for axial PsA. Results. The literature review revealed that new biologic and targeted synthetic disease-modifying antirheumatic drug classes could be considered for the treatment of axial PsA. Conclusion. Further studies are needed for a better understanding of the treatment of axial PsA.
JOURNAL OF RHEUMATOLOGY
(2023)
Article
Neurosciences
Caroline Kay, Rob Kuper, Elizabeth A. Becker
Summary: This study estimated the carbon emissions associated with the annual Society for Neuroscience (SfN) meeting in 2018 and proposed the adoption of virtual meetings connected by global hubs by 2030 and fully virtual meetings by 2050.
Article
Virology
Luciana Barros de Arruda, Fabricio Souza Campos, Jonatas Santos Abrahao, Flavio Guimaraes da Fonseca, Joao Pessoa Araujo Junior, Fernando Rosado Spilki
Summary: The 2020 edition of the Brazilian Society of Virology congress was held online for the first time due to the COVID-19 pandemic, attracting more than 921 participants. The meeting featured insightful talks from prominent national and international researchers on various aspects of virology and specifically focused on new data and perspectives regarding COVID-19.
Review
Rheumatology
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, Maria Julia Cura, Maria Esposito, Anthony P. Fernandez, Paolo Gisondi, Alessandro Giunta, Tom Hillary, Stefano Piaserico, James A. Solomon, Joseph F. Merola
Summary: This study aimed to summarize and evaluate the current evidence on the efficacy of therapies for cutaneous psoriasis in patients with psoriatic arthritis. The findings suggest that several pharmacologic therapeutic classes have high-quality evidence demonstrating efficacy for cutaneous psoriasis in the psoriatic arthritis population.
JOURNAL OF RHEUMATOLOGY
(2023)
Review
Medicine, General & Internal
A. Rej, A. Avery, I Aziz, C. J. Black, R. K. Bowyer, R. L. Buckle, L. Seamark, C. C. Shaw, J. Thompson, N. Trott, M. Williams, D. S. Sanders
Summary: There is a renewed interest in using dietary therapies to manage irritable bowel syndrome (IBS), with traditional dietary advice (TDA), gluten-free diet (GFD) and low FODMAP diet (LFD) being the main focus. Evidence shows that TDA is effective based on case control studies and clinical experience, while randomized controlled trials (RCT) have proven the benefits of soluble fiber in IBS. Short-term studies show the efficacy of GFD, but long-term outcomes are lacking. LFD has good evidence for short-term and long-term benefits. There is currently no evidence to suggest one diet is superior to another, but TDA is more acceptable to patients. Dietitians should assess dietary triggers and tailor interventions according to patient choice. Alternative approaches like group clinics and online webinars can improve accessibility for patients. Further research is needed to compare dietary therapies with other management strategies for IBS.
Review
Rheumatology
Ying-Ying Leung, Tatiana V. Korotaeva, Liliana Candia, Susanne Juhl Pedersen, Wilson Bautista Molano, Eric M. Ruderman, Radjesh Bisoendial, Rodolfo Perez-Alamino, Wendy Olsder, Burkhard Moeller, Simeon Grazio, Tania Gudu, Girish M. Mody, Carlos Pineda, Helena Raffayova, Sherry Rohekar, Claudia Goldenstein-Schainberg, Sergio R. Gutierrez Urena, Julio Cesar Casasola Vargas, Bhowmik Meghnathi, Roopa Prasad, Pascal Richette, Jose Roberto S. Miranda, Nikolas Malliotis, Ulla Lindqvist, David Simon, Amara Ezeonyeli, Enrique R. Soriano, Oliver FitzGerald
Summary: The objective of this study was to provide evidence for the efficacy and safety of therapeutic options for the peripheral arthritis domain of PsA for the revised 2021 GRAPPA treatment recommendations. Evidence was derived from new RCTs and recommendations were made for different patient groups based on their treatment history and response. Different classes of therapeutic options were strongly recommended for different patient groups.
JOURNAL OF RHEUMATOLOGY
(2023)